Takeda Pharmaceutical Co. Ltd. | Ownership
Companies that own Takeda Pharmaceutical Co. Ltd.
The Vanguard Group, Inc.
30,863,353
3.88%
32,752
0.04%
09/10/2018
Nomura Asset Management Co., Ltd.
25,101,996
3.16%
-474,315
0.59%
07/31/2018
Causeway Capital Management LLC
20,526,226
2.58%
21,800
1.94%
09/10/2018
Mondrian Investment Partners Ltd.
18,534,817
2.33%
-33,900
4.07%
09/10/2018
Wellington Management Co. LLP
15,650,141
1.97%
-2,200
0.12%
09/10/2018
BlackRock Fund Advisors
13,515,800
1.7%
-25,300
0.03%
09/06/2018
State Street Global Advisors Ltd.
12,878,259
1.62%
-3,651
0.61%
09/06/2018
Nikko Asset Management Co., Ltd.
12,742,700
1.6%
6,892,200
0.31%
01/31/2018
Daiwa Asset Management Co. Ltd.
11,560,300
1.46%
3,300
0.55%
09/10/2018
Barclays Bank Plc (Private Banking)
11,444,931
1.44%
-7,600
0.89%
09/10/2018
| Address |
4-1-1 Dosho-machi
Osaka Osaka 540
Japan
|
|
Employees
|
- |
| Website |
http://www.takeda.co.jp |
| Updated |
07/08/2019 |
| Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. |
